# Cadila Pharmaceuticals Limited - Inspection Records

Source: https://www.globalkeysolutions.net/companies/cadila-pharmaceuticals-limited/ea4ece29-89c9-42f3-9afa-58348dc605b9

> Inspection records and compliance data for Cadila Pharmaceuticals Limited in Ahmedabad, None. Access full analysis and detailed observations.

---

## Details

- Name: Cadila Pharmaceuticals Limited
- FEI Number: 3007684569
- City: Ahmedabad
- State: None
- Country Name: India
- Address Line 1: 1389 Trasad Road, Dholka
- Zip Code: None
- Business Operations: API/FDF ANALYTICAL TESTING, CLINICAL BIOEQUIVALENCE OR BIOAVAILABILITY STUDY, FDF MANUFACTURE, IN VITRO BIOEQUIVALENCE OR BIOANALYTICAL TESTING, PACK

## Related Documents

- [FDA Inspection 1293740 - Cadila Pharmaceuticals Limited - 2025-09-26](https://www.globalkeysolutions.net/records/fda_inspections/cadila-pharmaceuticals-limited/140a3822-4398-4af1-9f69-6778fa4a952d) — source: FDA, date: September 26, 2025
- [FDA Inspection 1293740 - Cadila Pharmaceuticals Limited - 2025-09-26](https://www.globalkeysolutions.net/records/fda_inspections/cadila-pharmaceuticals-limited/b991c75a-8fa3-4de4-8f98-9277d2ebe1a8) — classification: No Action Indicated (NAI), source: FDA, date: September 26, 2025
- [FDA Inspection 1205061 - Cadila Pharmaceuticals Limited - 2023-04-07](https://www.globalkeysolutions.net/records/fda_inspections/cadila-pharmaceuticals-limited/b255ba0d-baeb-4fb6-ae1a-18089e5910b3) — classification: No Action Indicated (NAI), source: FDA, date: April 7, 2023
- [FDA Inspection 1173461 - Cadila Pharmaceuticals Limited - 2022-06-17](https://www.globalkeysolutions.net/records/fda_inspections/cadila-pharmaceuticals-limited/5d7e1807-c56a-449f-95fe-2e7563d70d00) — classification: No Action Indicated (NAI), source: FDA, date: June 17, 2022
- [FDA Inspection 1120482 - Cadila Pharmaceuticals Limited - 2020-02-14](https://www.globalkeysolutions.net/records/fda_inspections/cadila-pharmaceuticals-limited/2033cf38-309c-4e24-a5ed-94b5fdf1206e) — classification: No Action Indicated (NAI), source: FDA, date: February 14, 2020
- [FDA Inspection 1052117 - Cadila Pharmaceuticals Limited - 2018-05-03](https://www.globalkeysolutions.net/records/fda_inspections/cadila-pharmaceuticals-limited/63f78d34-ad1d-4b85-87a0-067d7502a5cd) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 3, 2018
- [FDA Inspection 929697 - Cadila Pharmaceuticals Limited - 2015-05-15](https://www.globalkeysolutions.net/records/fda_inspections/cadila-pharmaceuticals-limited/33f945fd-5c91-4138-b447-ec65d0b2b111) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 15, 2015
- [WARNING_LETTER - Cadila Pharmaceuticals Limited - 2014-03-28](https://www.globalkeysolutions.net/records/warning_letter/cadila-pharmaceuticals-limited/e632d2bc-00bb-46bd-af88-c34895517e74) — source: FDA, date: March 28, 2014
- [FDA Inspection 801838 - Cadila Pharmaceuticals Limited - 2012-09-21](https://www.globalkeysolutions.net/records/fda_inspections/cadila-pharmaceuticals-limited/df9c22e5-038e-4a48-a7fd-03ee40f2346c) — classification: No Action Indicated (NAI), source: FDA, date: September 21, 2012

## Related Companies

- [Haleon US Inc.](https://www.globalkeysolutions.net/companies/haleon-us-inc/59f65cda-88dc-4ec6-98a9-42bd852cb203)
- [Wyeth Farma SA](https://www.globalkeysolutions.net/companies/wyeth-farma-sa/e7e491e8-2e72-4e18-a3f3-7ae5a99e69b8)
- [Takeda GmbH, Plant Oranienburg](https://www.globalkeysolutions.net/companies/takeda-gmbh-plant-oranienburg/c72ad117-1d9b-474a-8d1a-c4d0e81e9ba8)
- [Thymoorgan Pharmazie Gmbh](https://www.globalkeysolutions.net/companies/thymoorgan-pharmazie-gmbh/b58b84eb-57d4-4730-8fbb-58632f71023d)
- [Merck Serono S.p.A.](https://www.globalkeysolutions.net/companies/merck-serono-spa/052a4b09-0189-4f5c-bdcc-33182a7d3488)
- [Siegfried El Masnou, S.A.](https://www.globalkeysolutions.net/companies/siegfried-el-masnou-sa/7d454af3-32c0-4c5d-b7cb-c11d6cd5096b)
- [MannKind Corporation](https://www.globalkeysolutions.net/companies/mannkind-corporation/b311f335-89a1-47a3-a7dc-24d2943cf1d4)
- [Lilly France S.A.S.](https://www.globalkeysolutions.net/companies/lilly-france-sas/27fa7368-5fb0-48b1-b161-5729c7bfa061)
- [Alphapharm Pty, Ltd.](https://www.globalkeysolutions.net/companies/alphapharm-pty-ltd/9007b3c5-9b83-4783-b65d-52eb0246708e)
- [AstraZeneca Pharmaceuticals LP](https://www.globalkeysolutions.net/companies/astrazeneca-pharmaceuticals-lp/80a406f0-7f62-4d81-841e-7f01c9950c06)

## Related Officers

- [Thomas J. Cosgrove](https://www.globalkeysolutions.net/people/thomas-j-cosgrove/616abec3-5ed9-42aa-9f5d-392b5552b695)